RxDoctor Payments DataLook up a doctor →

Matthew Morgan, DO

Family Medicine · Northglenn, CONPI 1457322943

Payments from drug & device makers

$44,556in general payments, 2019–2025

Across 1,136 payments — averaging $39.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sekisui Diagnostics LLC$21K
  • Orasure Technologies Inc.$5K
  • AbbVie$3K
  • AstraZeneca$3K
  • GSK$1K
  • Boehringer Ingelheim$1K
  • plus $11K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sekisui Diagnostics LLC2$20,725
Orasure Technologies Inc.2$4,650
AbbVie(2 entities)206$3,229
AstraZeneca126$2,797
GSK78$1,391
Boehringer Ingelheim66$1,188
Novo Nordisk81$1,171
Amgen59$968
Lilly USA, LLC67$949
Johnson & Johnson42$744
Pfizer50$724
Abbott24$474
Bayer35$466
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC33$437
Astellas Pharma US Inc23$416
Novartis17$340
Teva Pharmaceuticals USA, Inc.15$334
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)12$288
Eisai Inc.28$267
Esperion Therapeutics, Inc.13$262
Exact Sciences9$217
Merck14$203
Regeneron Healthcare Solutions, Inc.6$202
Biohaven Pharmaceuticals, Inc.16$193
Biohaven Pharmaceutical Holding Company Ltd.14$182
Amarin Pharma, Inc.10$176
Idorsia Pharmaceuticals US Inc13$162
E.r. Squibb & Sons, L.L.C.5$94
Otsuka America Pharmaceutical, Inc.4$94
Nestle Healthcare Nutrition Inc.5$86
Kowa Pharmaceuticals America, Inc.5$82
Takeda Pharmaceuticals U.S.A., Inc.4$79
Sunovion Pharmaceuticals Inc.4$78
Inspire Medical Systems, Inc.1$72
Daiichi Sankyo Inc.4$71
Aimmune Therapeutics, Inc.4$66
Sanofi-aventis U.S. LLC4$64
Axsome Therapeutics, Inc.2$49
Paratek Pharmaceuticals, Inc.2$43
Jazz Pharmaceuticals Inc.3$42
Shire North American Group Inc3$42
Intuitive Surgical1$40
Sumitomo Pharma America, Inc.3$39
Dexcom, Inc.2$37
Heartflow, Inc.2$35
Scilex Pharmaceuticals Inc.2$32
Genentech USA, Inc.2$30
Endo Pharmaceuticals Inc.2$27
Phathom Pharmaceuticals, Inc.1$26
Dermira, Inc.1$22
Mannkind Corporation1$18
Corium, LLC1$18
Lucid Diagnostics Inc.1$17
Xeris Pharmaceuticals, Inc.1$17
Circassia Inc.1$17
IBSA Pharma Inc.1$16
Sanofi Pasteur Inc.1$16
Neos Therapeutics, LP1$16
Dynavax Technologies Corporation1$14

How this compares

$44,556 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$37,160
Medicare patients
153
Services billed
8,529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Northglenn

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →